Cargando…
Neuroprotective Effects of Intermittent Theta Burst Stimulation in Parkinson’s Disease (NET-PD): A Study Protocol for a Delayed-Start Randomized Double-Blind Sham-Controlled Trial
Background: As a typical high-disability neurodegenerative disease, Parkinson’s disease (PD) progresses variably, and patients who are clinically insensitive to dopaminergic therapy and whose symptoms fail to improve are commonly observed. As a result, achieving early neuron protection is critical....
Autores principales: | Li, Puyu, Luo, Ningdi, Sun, Sainan, Li, Yuanyuan, Shen, Dingding, Zhu, Xue, Zhou, Liche, Zhou, Haiyan, Liu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456365/ https://www.ncbi.nlm.nih.gov/pubmed/36078903 http://dx.doi.org/10.3390/jcm11174972 |
Ejemplares similares
-
Pain trajectories of dorsomedial prefrontal intermittent theta burst stimulation versus sham treatment in depression
por: Malm, Erika, et al.
Publicado: (2020) -
Intermittent theta burst stimulation for negative symptoms of schizophrenia—A double-blind, sham-controlled pilot study
por: Bation, Rémy, et al.
Publicado: (2021) -
Sham-derived effects and the minimal reliability of theta burst stimulation
por: Boucher, P. O., et al.
Publicado: (2021) -
Efficacy and safety of intermittent theta-burst stimulation in patients with schizophrenia: A meta-analysis of randomized sham-controlled trials
por: Goh, Kah Kheng, et al.
Publicado: (2022) -
Accelerated Intermittent Theta Burst Stimulation for Suicide Risk in Therapy-Resistant Depressed Patients: A Randomized, Sham-Controlled Trial
por: Desmyter, Stefanie, et al.
Publicado: (2016)